3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Motor Activity
12
Colonic Neoplasms
8
Colorectal Neoplasms
7
Rectal Neoplasms
6
Breast Neoplasms
6
Stomach Neoplasms
5
Neoplasms
4
Lung Neoplasms
4
Esophageal Neoplasms
4
Prostatic Neoplasms
3
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Head and Neck Neoplasms
3
Urinary Bladder Neoplasms
2
Smoking Cessation
2
Postoperative Complications
2
Insulin Resistance
2
Frailty
2
Disease
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma, Hepatocellular
2
Urologic Neoplasms
1
Smoking
1
Risk Reduction Behavior
1
Patient Preference
1
Pancreatitis, Chronic
1
Pain
1
Obesity
1
Nutrition Disorders
1
Metabolic Syndrome
1
Interventions
aldesleukin
42
Sunitinib
39
Cyclophosphamide
30
Nivolumab
27
Everolimus
27
pembrolizumab
26
Interferon-alpha
25
Bevacizumab
22
Sorafenib
21
Interleukin-2
20
fludarabine phosphate
19
Filgrastim
18
Ipilimumab
17
Radiotherapy
16
Axitinib
16
Peripheral Blood Stem Cell Transplantation
15
Gemcitabine
15
cabozantinib
14
fludarabine
11
Radiosurgery
11
Doxorubicin
11
Carboplatin
11
temsirolimus
10
Etoposide
9
Chemotherapy, Adjuvant
9
sargramostim
8
belzutifan
8
atezolizumab
8
Fluorouracil
8
pazopanib
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Kidney Neoplasms
×
Preoperative Exercise
×
Clear all
NCT06745609
2025-01-24
Pre-KiT
Herlev and Gentofte Hospital
Phase NA
Recruiting
60 enrolled